FMCCI Stock | News | Quote | Stock Forum | Thursday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Freddie Mac FMCCI Company Overview 

Stock Message Board http://investorshangout.com/search?q=FMCCI&am...mp;yt1=Go!

Last Updated: Thursday, October 24, 2013 7:42:59 PM

Freddie Mac FMCCI Current Price and Quotes
Last Price 10.50
Previous Close 9.90 Open 10.00
Daily Range 10.50 - 9.98 52wk Range 11.70 - 2.20
Volume 2,750 Dividend N/A
Average Vol (3m) 1,698 Yield N/A
Freddie Mac FMCCI
Company Information

8200 Jones Branch Drive
McLean, VA 22102

Website: http://www.freddiemac.com
Phone: 703-903-2000

Freddie Mac FMCCI
Freddie Mac was chartered by Congress in 1970 with a public mission to stabilize the nation’s residential mortgage markets and expand opportunities for home ownership and affordable rental housing.

Freddie Mac FMCCI
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001026214
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6111 - Federal and federally sponsored credit
Incorporated In: USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Donald H. Layton CEO
Ross J. Kari CFO
John R. Dye Senior VP, Corporate Secretary
Company Directors

Not Available
Company Notes

Formerly=Federal Home Loan Mortgage Corp. until 7-97
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Freddie Mac FMCCI
FMCCI Security Details Other Company Securities

Share Structure

Market Value1 $49,500,000 a/o Oct 23, 2013
Shares Outstanding 5,000,000 a/o Apr 26, 1996
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend () Jun 13, 2002 Jun 17, 2002 Jun 28, 2002
Short Selling Data

Short Interest 100 (-65.64%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Freddie Mac FMCCI Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 80,635,000 88,262,000 98,368,000 37,614,000
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 2,193,000 2,483,000 2,932,000 7,195,000
Non-Recurring Items - - - -
Other 1,890,000 10,702,000 17,218,000 29,530,000
Operating Income - - - -
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 76,552,000 75,077,000 78,218,000 889,000
Interest Expense 67,107,000 80,743,000 93,100,000 23,273,000
Earnings Before Tax 9,445,000 (5,666,000) (14,882,000) (22,384,000)
Income Tax (1,537,000) (400,000) (856,000) (830,000)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Preferred Stock and Other Adjustments (13,056,000) (6,498,000) (5,749,000) (4,105,000)
Net Income Applicable to Common Shareholders (2,074,000) (11,764,000) (19,774,000) (25,658,000)

Freddie Mac FMCCI Recent News

FMCCI Freddie Mac Research DD Guide

Stock Message Board http://investorshangout.com/search?q=FMCCI&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/FMCCI/quote
Stock Chart http://www.otcmarkets.com/stock/FMCCI/chart
Company Info http://www.otcmarkets.com/stock/FMCCI/company-info
Recent News http://www.otcmarkets.com/stock/FMCCI/news
Financials http://www.otcmarkets.com/stock/FMCCI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/FMCCI/filings
Short Sales http://www.otcmarkets.com/stock/FMCCI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/FMCCI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/FMCCI/research
Summary http://finance.yahoo.com/q?s=FMCCI
Historical Prices http://finance.yahoo.com/q/hp?s=FMCCI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=FMCCI
Basic Chart http://finance.yahoo.com/q/bc?s=FMCCI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FMCCI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=FMCCI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=FMCCI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=FMCCI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=FMCCI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=FMCCI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=FMCCI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=FMCCI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=FMCCI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=FMCCI
Balance Sheet http://finance.yahoo.com/q/bs?s=FMCCI
Cash Flow http://finance.yahoo.com/q/cf?s=FMCCI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/FMCCI
Market Watch http://www.marketwatch.com/investing/stock/FMCCI
Bloomberg http://www.bloomberg.com/quote/FMCCI:US
Morningstar http://quotes.morningstar.com/stock/s?t=FMCCI
Bussinessweek http://investing.businessweek.com/research/st...cker=FMCCI
Barchart http://www.barchart.com/quotes/stocks/FMCCI
OTC Short Report http://otcshortreport.com/index.php?index=FMCCI
Investopedia http://www.investopedia.com/markets/stocks/FMCCI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 85

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 52

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 110

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

DESRI Completes Major Financing for Texas Solar Projects

Updated Category News Views 324

DESRI Completes Major Financing for Texas Solar Projects Today, DESRI proudly announced that it has closed a significant preferred equity financing of $129 million aimed at a 250-megawatt (MWac) solar development portfolio. This portfolio consists of two innovative solar projects located in West Texas, an area ripe for renewable energy enhancement. Meeting Industrial...

Continue Reading
Colossal Foundation Invests $500,000 in Condor Restoration Efforts

Updated Category News Views 76

Colossal Foundation Invests in Wildlife Recovery The Colossal Foundation has made a significant commitment of $500,000 towards restoring the California condor to its ancestral skies. This incredible movement represents a decade-long partnership with the Nez Perce Tribe, focusing on the recovery and reintroduction of North America’s largest land bird. For more than a...

Continue Reading
Revolutionary Self-Healing Film: The Future of Waterproofing

Updated Category News Views 108

Revolutionary Waterproofing Solutions by Charter Next Generation Charter Next Generation (CNG) recently unveiled its groundbreaking Nail Sealable film technology, designed to transform waterproofing in the construction industry. This pioneering self-healing film stands out with its exceptional moisture resistance and remarkable durability, making it a game changer for...

Continue Reading
Sonnet BioTherapeutics Provides Positive Safety Insights on SON-1010

Updated Category News Views 273

Exciting Safety Data from Sonnet BioTherapeutics’ SON-1010 Trial Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) has unveiled impressive topline safety data following a successful dose escalation of SON-1010 in the Phase 1 SB101 clinical trial. The study focused on the administration of SON-1010 to patients suffering from advanced solid tumors, marking a significant...

Continue Reading
Key Legal Information for Symbotic Inc. Shareholders

Updated Category News Views 73

Important Information for Symbotic Inc. Investors Recent developments surrounding Symbotic Inc. have captured the attention of investors globally. Investors who are shareholders of Symbotic Inc. (NASDAQ: SYM) may need to be aware of significant deadlines regarding a recent securities class action lawsuit. Overview of the Lawsuit Investors are reminded that they may have...

Continue Reading